SPRY
ARS Pharmaceuticals Inc

2,447
Mkt Cap
$1.01B
Volume
284,922.00
52W High
$18.90
52W Low
$6.66
PE Ratio
-12.61
SPRY Fundamentals
Price
$10.25
Prev Close
$10.06
Open
$10.09
50D MA
$10.23
Beta
1.26
Avg. Volume
1.58M
EPS (Annual)
$0.0781
P/B
6.84
Rev/Employee
$557,181.25
Loading...
Loading...
News
all
press releases
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) have earned an average rating of "Moderate Buy" from the six analysts that are currently covering the stock, MarketBeat.com...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 12.3% - Should You Sell?
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 12.3% - Time to Sell...
MarketBeat·18d ago
News Placeholder
SPRY Makes Bullish Cross Above Critical Moving Average
In trading on Friday, shares of ARS Pharmaceuticals Inc (Symbol: SPRY) crossed above their 200 day moving average of $12.77, changing hands as high as $13.01 per share. ARS Pharmaceuticals Inc shares...
Nasdaq News: Markets·21d ago
News Placeholder
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company...
MarketBeat·28d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 3.4% - Time to Buy?
ARS Pharmaceuticals (NASDAQ:SPRY) Trading 3.4% Higher - Here's Why...
MarketBeat·1mo ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Trading 7.9% Higher - What's Next?
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 7.9% - Should You Buy...
MarketBeat·1mo ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 6.3% - Time to Buy?
ARS Pharmaceuticals (NASDAQ:SPRY) Trading 6.3% Higher - What's Next...
MarketBeat·2mo ago
News Placeholder
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Consensus Rating of "Moderate Buy" from Analysts
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the stock...
MarketBeat·2mo ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 8.1% - Here's What Happened
ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 8.1% - What's Next...
MarketBeat·2mo ago
News Placeholder
Franklin Resources Inc. Sells 28,789 Shares of ARS Pharmaceuticals, Inc. $SPRY
Franklin Resources Inc. trimmed its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 1.5% during the second quarter, according to the company in its most recent disclosure...
MarketBeat·2mo ago
<
1
2
...
>

Latest SPRY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.